In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
Electric cars, climate credit schemes, diverse boardrooms and legal weed: How California exports its ideas and policies across the U.S. For many of the hundreds of thousands of Venezuelan immigrants ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback